Decreasing cardiovascular risk in HIV infection between 2005 and 2011

AIDS

Volumn 28, Issue 4, 2014, Pages 609-612

  De Socio, Giuseppe V ^a   Parruti, Giustino ^b   Ricci, Elena ^c   Maggi, Paolo ^d   Celesia, Benedetto M ^e   Penco, Giovanni ^f   Martinelli, Canio ^g   Franzetti, Marco ^h   Di Biagio, Antonio ⁱ   Bonfanti, Paolo ^j   Pucci, Giacomo ^a   Schillaci, Giuseppe ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b Pescara Hospital   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF BARI   (Italy)

^e UNIVERSITY OF CATANIA   (Italy)

^f GALLIERA HOSPITAL   (Italy)

^g CAREGGI UNIVERSITY HOSPITAL   (Italy)

^h UNIVERSITY OF MILAN   (Italy)

ⁱ UNIVERSITY OF GENOA   (Italy)

^j A MANZONI HOSPITAL   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CARDIOVASCULAR DISEASES; FEMALE; HIV INFECTIONS; HUMANS; ITALY; MALE; MIDDLE AGED; RISK ASSESSMENT;

EID: 84895068162     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000181     Document Type: Article

References (16)

1. Hogg R, Lima V, Sterne JA, Grabar S, Battegay M, Bonarek M, et al. Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: A collaborative analysis of 14 cohort studies. Lancet 2008; 372:293-299.
2. Freiberg MS, Chang CC, Kuller LH, Skanderson M, Lowy E, Kraemer KL, et al. HIV infection and the risk of acute myocardial infarction. JAMA Intern Med 2013; 173:614-622.
3. EACS guidelines, version 6.0. Web. 2011. http://www. europeanaidsclinicalsociety. org/images/stories/EACS-Pdf/eacsguidelines-6.pdf. [Accessed 31 August 2013].
4. Volberding PA, Deeks SG. Antiretroviral therapy and management of HIV infection. Lancet 2010; 376:49-62.
5. Bonfanti P, Ricci E, De Socio G, Zeme D, Carradori S, Penco G, et al., CISAI Study Group. Metabolic syndrome: A real threat for HIV-positive patients Results from the SIMONE study. J Acquir Immune Defic Syndr 2006; 42:128-131.
6. De Socio GV, Ricci E, Maggi P, Parruti G, Pucci G, Di Biagio A, et al., CISAI Study Group. Prevalence, awareness, treatment and control rate of hypertension in HIV-infected patients: The HIV-HY study. Am J Hypertens 2014; 27:222-228.
7. Dagostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: The Framingham Heart study. Circulation 2008; 117:743-753.
8. De Socio GV, Ricci E, Parruti G, Maggi P, Madeddu G, Quirino T, Bonfanti P. Chronological and biological age in HIV infection. J Infect 2010; 61:428-430.
9. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al., International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120:1640-1645.
10. De Socio GV, Parruti G, Quirino T, Ricci E, Schillaci G, Adriani B, et al., for the CISAI study group. Identifying HIV patients with an unfavorable cardiovascular risk profile in clinical practice: Results from the SIMONE study. J Infect 2008; 57:33-40.
11. Dobiásová M, Frohlich J. The plasma parameter log (TG/HDLC) as an atherogenic index: Correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FERHDL). Clin Biochem 2001; 34:583-588.
12. Barone-Adesi F, Vizzini L, Merletti F, Richiardi L. Short-term effects of Italian smoking regulation on rates of hospital admission for acute myocardial infarction. Eur Heart J 2006; 27:2468-2472.
13. De Socio GV, Bonfanti P, Martinelli C, Ricci E, Pucci G, Marinoni M, et al. Negative influence of HIV infection on day-night blood pressure variability. J Acquir Immune Defic Syndr 2010; 55:356-360.
14. Schillaci G, Maggi P, Madeddu G, Pucci G, Mazzotta E, Penco G, et al., for the CISAI Study Group. Symmetric ambulatory arterial stiffness index and 24-h pulse pressure in HIV infection: Results of a nationwide cross-sectional study. J Hypertens 2013; 31:560-567.
15. Schillaci G, Pucci G, De Socio GV. HIV infection and antiretroviral treatment: A two-hit model for arterial stiffnessAm J Hypertens 2009; 22:817-818.
16. Bonfanti P, De Socio GL, Marconi P, Franzetti M, Martinelli C, Vichi F, et al. Is metabolic syndrome associated to HIV infection per se Results from the HERMES study. Curr HIV Res 2010; 8:165-171.